- Home
- USNA vs MGTX Comparison
USNA vs MGTX Comparison
Compare USNA & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USNA
- MGTX
- Stock Information
- Founded
- USNA 1992
- MGTX 2015
- Country
- USNA United States
- MGTX United States
- Employees
- USNA N/A
- MGTX N/A
- Industry
- USNA Medicinal Chemicals and Botanical Products
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- USNA Health Care
- MGTX Health Care
- Exchange
- USNA Nasdaq
- MGTX Nasdaq
- Market Cap
- USNA 565.2M
- MGTX 524.0M
- IPO Year
- USNA 1996
- MGTX N/A
- Fundamental
- Price
- USNA $32.77
- MGTX $7.60
- Analyst Decision
- USNA Hold
- MGTX Strong Buy
- Analyst Count
- USNA 1
- MGTX 2
- Target Price
- USNA $36.00
- MGTX $24.00
- AVG Volume (30 Days)
- USNA 157.7K
- MGTX 460.2K
- Earning Date
- USNA 07-22-2025
- MGTX 08-11-2025
- Dividend Yield
- USNA N/A
- MGTX N/A
- EPS Growth
- USNA N/A
- MGTX N/A
- EPS
- USNA 1.82
- MGTX N/A
- Revenue
- USNA $876,242,000.00
- MGTX $34,508,000.00
- Revenue This Year
- USNA $13.04
- MGTX $365.04
- Revenue Next Year
- USNA $7.36
- MGTX $73.18
- P/E Ratio
- USNA $18.04
- MGTX N/A
- Revenue Growth
- USNA N/A
- MGTX 203.23
- 52 Week Low
- USNA $23.10
- MGTX $3.85
- 52 Week High
- USNA $48.85
- MGTX $8.75
- Technical
- Relative Strength Index (RSI)
- USNA 68.33
- MGTX 71.28
- Support Level
- USNA $30.36
- MGTX $6.31
- Resistance Level
- USNA $31.43
- MGTX $6.80
- Average True Range (ATR)
- USNA 0.82
- MGTX 0.38
- MACD
- USNA 0.18
- MGTX 0.07
- Stochastic Oscillator
- USNA 98.86
- MGTX 97.96
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.